Ardelyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. 

CEO
Michael G. Raab
CEOMichael G. Raab
Employees
395
Employees395
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
395
Employees395

ARDX Key Statistics

Market cap
1.89B
Market cap1.89B
Price-Earnings ratio
-32.80
Price-Earnings ratio-32.80
Dividend yield
Dividend yield
Average volume
7.54M
Average volume7.54M
High today
$8.40
High today$8.40
Low today
$7.76
Low today$7.76
Open price
$7.92
Open price$7.92
Volume
4.24M
Volume4.24M
52 Week high
$8.40
52 Week high$8.40
52 Week low
$3.21
52 Week low$3.21

Stock Snapshot

Ardelyx(ARDX) stock is priced at $7.85, giving the company a market capitalization of 1.89B. It carries a P/E multiple of -32.80.

As of 2026-01-24, Ardelyx(ARDX) stock has fluctuated between $7.76 and $8.40. The current price stands at $7.85, placing the stock +1.1% above today's low and -6.6% off the high.

The Ardelyx(ARDX)'s current trading volume is 4.24M, compared to an average daily volume of 7.54M.

During the past year, Ardelyx(ARDX) stock moved between $3.21 at its lowest and $8.40 at its peak.

During the past year, Ardelyx(ARDX) stock moved between $3.21 at its lowest and $8.40 at its peak.

ARDX News

Nasdaq 4d
Strength Seen in Ardelyx: Can Its 15.0% Jump Turn into More Strength?

Ardelyx (ARDX) shares ended the last trading session 15% higher at $7.76. The jump came on an impressive volume with a higher-than-average number of shares chan...

Strength Seen in Ardelyx: Can Its 15.0% Jump Turn into More Strength?
Simply Wall St 4d
Ardelyx, Inc. Stock Catapults 37% Though Its Price And Business Still Lag The Industry

Ardelyx, Inc. ( ) shares have continued their recent momentum with a 37% gain in the last month alone. The last 30 days bring the annual gain to a very sharp 58...

Ardelyx, Inc. Stock Catapults 37% Though Its Price And Business Still Lag The Industry
Seeking Alpha 4d
Ardelyx gains on report Zydus Lifesciences in talks to purchase

Ardelyx (ARDX) rose 12% on a report that Zydus Lifesciences is in talks to purchase the company. Zydus may seek to acquire control of Ardelyx or purchase selec...

Ardelyx gains on report Zydus Lifesciences in talks to purchase

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.